Adam S. Mostafa, Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 52,500 shares at $0.88 ($46K) on 2024-03-11, disclosed to the SEC on 2024-03-11.
Scheduled sale ($46k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XFOR | SELL | 2024-02-12 | $28K | — | Filing → |
| XFOR | SELL | 2023-11-03 | $337K | — | Filing → |
| XFOR | SELL | 2023-07-05 | $5K | — | Filing → |